• 1
    Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994; 84: 324327.
  • 2
    Price RN. Artemisinin drugs: novel antimalarial agents. Expert Opin Invest Drugs 2000; 9: 18151827.
  • 3
    Li GQ, Guo X, Jim R, Wang Z, Jian H. Clinical studies on treatment of cerebral malaria with quinghasosu and its derivatives. J Trad Chinese Med 1982; 2: 125130.
  • 4
    White NJ. The treatment of malaria. N Engl J Med 1996; 335: 800806.
  • 5
    De Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996; 52: 818836.
  • 6
    Van Agtmael MA, Eggelte TA, Van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci 1999; 20: 199205.
  • 7
    Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. C. linical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand: a preliminary report. Southeast Asian J Trop Med Public Health 1991; 22: 380385.
  • 8
    Looareeswuan S, Wilairatana P, Vanijanonta S, et al. A randomised trial of mefloquine, artesunate, and artesunate followed by mefloquine in acute uncomplicated falciparum malaria. Lancet 1992; 339: 821824.
  • 9
    Karbwang J, Bangchang KN, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet 1992; 340: 12451248.
  • 10
    Gu HM, Lu BF, Qu ZX. Antimalarial activities of 25 derivatives of artemisinin against chloroquine-resistant Plasmodium berghei. Acta Pharmacol Sinica 1980; 1: 4850.
  • 11
    China Cooperative Research Group on Qinghaosu. Antimalarial efficacy and mode of action of qinghaosu and its derivatives in experimental models. J Trad Chin Med 1982; 2: 1724.
  • 12
    Wu JA, Ji RY. A quantitative structure-activity study on artemisinin analogues (Engl. Abstract). Acta Pharmacol Sinica 1982; 3: 5560.
  • 13
    Davidson DE Jr. Role of arteether in the treatment of malaria and plans for further development. Trans R Soc Trop Med Hyg 1994; 88(Suppl 1): S51S52.
  • 14
    Shmuklarsky MJ, Klayman DL, Milhous WK, et al. Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo. Am J Trop Med Hyg 1993; 48: 377384.
  • 15
    Li QG, Peggins JO, Fleckenstein LL, Masonic K, Heiffer MH, Brewer TG. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 1998; 50: 173182.
  • 16
    Brossi A, Venugopalan B, DominguezGerpe L, et al. Arteether a new anti-malarial drug. synthesis and anti-malarial properties. J Med Chem 1988; 31: 645650.
  • 17
    Peeters PAM, Van Lier JJ, Oosterhuis B, et al. A placebo-controlled study on the tolerability and pharmacokinetics of multiple dose artemotil in healthy volunteers. in press.
  • 18
    Thuma TE, Bhat GJ, Mabeza GF, et al. A randomised controlled trial of artemotil (β-arteether) in Zambian children with cerebral malaria. Am J Trop Medical Hyg 2000; 62: 524529.
  • 19
    Moyou-Somo R, Tietche F, Ondoa M, et al. Clinical trial of beta-arteether versus quinine for the treatment of cerebral malaria in children in Yaounde, Cameroon. Am J Trop Med Hyg 2001; 64: 229232.
  • 20
    Looareesuwan S, Oosterhuis B, Schillizi BM, et al. A randomised trial to compare the efficacy of artemotil and artemether in the treatment of adult Thai patients with severe malaria. in press.
  • 21
    Oosterhuis B, Looaresuwan S, Krudsood S, et al. Comparison of artemotil and artemether for the treatment of moderate-to-severe malaria in Thai children: a double-blind randomised trial. submitted.
  • 22
    Warrell DA, Molyneux ME, Beales PF. Severe and Complicated Malaria, 2nd edn. Trans R Soc Trop Medical Hyg 1990; 84(Suppl 2): 165.
  • 23
    Melendez V, Peggins JO, Brewer TG, Theoharides AD. Determination of the anti-malarial arteether and its deethylated metabolite dihydroartemisinin in plasma by high-performance liquid chromatograpphy with reductive electrochemical detection. J Pharm Sci 1991; 80: 132138.
  • 24
    Teja-Isavadharm P, Nosten F, Kyle DE, et al. Comparative bioavailability of oral, rectal and intramuscular artemether in healthy subjects: use of simultaneous measurements by high performance liquid chromatography and bioassay. Br J Clin Pharmacol 1996; 42: 599604.
  • 25
    Karbwang J, Na-Bangchang K, Congpuong K, Molunto P, Thanavibul A. Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur J Clin Pharmacol 1997; 52: 307310.
  • 26
    Karbwang J, Na-Bangchang K, Tin T, Sukontason K, Rimchala W, Harinasuta T. Pharmacokinetics of intramuscular artemether in patients with severe falciparum malaria with or without acute renal failure. Br J Clin Pharmacol 1998; 45: 597600.
  • 27
    Kokwaro GO. Bioavailability of artemether. Br J Clin Pharmacol 1997; 44: 305.
  • 28
    Navaratnam V, Mansor SM, Sit N-W, Grace J, Li Q, Olliaro P. Pharmacokinetics of artemisinin-like compounds. Clin Pharmacokinet 2000; 39: 255270.
  • 29
    Murphy SA, Mberu E, Muhia D, et al. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg 1997; 91: 331334.
  • 30
    Kyle DE, Webster HK. Post-antibiotic effect of quinine and dihydroartemisinin on Plasmodium falciparum in vitro: implication for a mechanism of recrudescence. Abstract XIV International Congress for Tropical Medicine and Malaria Nagasaki Japan November 1722, 1996.